Key facts
- This page summarizes Stephen Gordon's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jun 2024, 17:12.
Stephen Gordon - 03 Jun 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- TMDX
- Reported as of
- 03 Jun 2024
- Net transaction value
- -$200,788
- SEC form
- 4
- Accepted by SEC
- 05 Jun 2024, 17:12:25 UTC
- Prior SEC filing
- 31 May 2024
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Stephen Gordon
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Stephen Gordon filed Form 4 for TransMedics Group, Inc. (TMDX) on 05 Jun 2024.
Change
- Previous filing in this sequence was filed on 31 May 2024.
- Current net transaction value: -$200,788.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $79,228
- Shares
- +2,060
- Change %
- +9.7%
- Price
- $38.46
- Shares after
- 23,359
- Date
- 03 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Sale
- Transaction value
- -$280,016
- Shares
- -2,060
- Change %
- -8.8%
- Price
- $135.93
- Shares after
- 21,299
- Date
- 03 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,060
- Change %
- -12%
- Price
- $0.000000
- Shares after
- 15,417
- Date
- 03 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,060
- Exercise price
- $38.46
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
Footnote F2
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.